Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Abdominal Metastases.

Kazuharu ChibaTatsuo HataMasamichi MizumaKunihiro MasudaShuichi AokiTatsuyuki TakadateKei KawaguchiKei NakagawaTakanori MorikawaFuyuhiko MotoiToru FurukawaMichiaki Unno

Published in: Annals of surgical oncology (2021)

Tumor-derived DNA in AS can serve as characterizing the genetic profiles of tumor cells attributable to the development of PER+ and predicting the minimal residual disease and early recurrence in patients with pancreatic cancer.

Keyphrases

circulating tumor
cell free
single molecule
genome wide
nucleic acid
dna methylation
copy number